Platzbecker, Uwe
Uwe Platzbecker researcher
VIAF ID: 17954971 (Personal)
Permalink: http://viaf.org/viaf/17954971
Preferred Forms
- 100 1 _ ‡a Platzbecker, Uwe
-
-
- 100 1 _ ‡a Platzbecker, Uwe
- 100 1 _ ‡a Platzbecker, Uwe
- 100 0 _ ‡a Uwe Platzbecker ‡c researcher
4xx's: Alternate Name Forms (5)
5xx's: Related Names (1)
Works
Title | Sources |
---|---|
Accurate quantification of chromosomal lesions via short tandem repeat analysis using minimal amounts of DNA | |
Allogeneic hematopoietic stem cell transplantation in patients aged 60-79 years in Germany (1998-2018): a registry study | |
Azacitidin prophylaktische Maßnahmen und Therapiemanagement ; Nebenwirkungen erkennen, vermeiden, behandeln | |
Biology-driven approaches to prevent and treat relapse of myeloid neoplasia after allogeneic hematopoietic stem cell transplantation | |
Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study | |
Efficacy and safety of ruxolitinib in patients with newly-diagnosed polycythemia vera futility analysis of the RuxoBEAT clinical trial of the GSG-MPN study group | |
Funktionelle Charakterisierung und prognostische Bedeutung von Dectin-1-Varianten für das Auftreten infektiologischer Komplikationen bei Patienten mit akuter myeloischer Leukämie | |
human leukocyte antigen-DPB1 degree of compatibility is determined by its expression level and mismatch permissiveness: a german multicenter analysis | |
Immunprofil von Patienten mit fortgeschrittenen Myelodysplastischen Syndromen oder Akuten Myeloischen Leukämien unter der gegen CD123 gerichteten Therapie mit Talacotuzumab | |
Impaired Overall Survival in Young Patients With Acute Myeloid Leukemia and Variants in Genes Predisposing for Myeloid Malignancies | |
Integrative study of EZH2 mutational status, copy number, protein expression and H3K27 trimethylation in AML/MDS patients | |
Kidney Dysfunction Is Associated with Thrombosis and Disease Severity in Myeloproliferative Neoplasms: Implications from the German Study Group for MPN Bioregistry | |
Late treatment-related mortality versus competing causes of death after allogeneic transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia | |
Mesenchymal stromal cells from patients with myelodyplastic syndrome display distinct functional alterations that are modulated by lenalidomide | |
Monosomal karyotype and chromosome 17p loss or TP53 mutations in decitabine-treated patients with acute myeloid leukemia | |
Myelodysplasia is in the niche: novel concepts and emerging therapies | |
Myelodysplastic Syndromes Diagnosis - Prognosis - Therapy | |
P573: Pharmacokinetic exposure equivalence and preliminary efficacy and safety from a randomized cross over phase 3 study of an oral hypomethylating agent dec-c compared to iv decitabine in aml patients | |
Prognostic value of CPSS cytogenetic risk classification in patients with CMML after allogeneic hematopoietic cell transplantation: a retrospective multicenter study of the Chronic Malignancies Working Party of the EBMT | |
Tierexperimentelle Untersuchungen zur Resorbierbarkeit von drei neuentwickelten porösen Biogläsern, Bioglaskeramiken |